Do ACE inhibitors or ARBs help prevent kidney disease in patients with diabetes and normal BP?

Q: Do ACE inhibitors or ARBs help prevent kidney disease in patients with diabetes and normal BP? Evidence-based answer: Yes for angiotensin-converting enzyme (ACE) inhibitors, no for angiotensin receptor blockers (ARBs). In normotensive patients with type 1 and type 2 diabetes, ACE inhibitor therapy reduces the risk of developing diabetic kidney disease, defined as new-onset microalbuminuria or macroalbuminuria, by 18% (strength of recommendation [SOR]: C, meta-analysis of randomized controlled trials [RCTs], disease-oriented evidence). ACE inhibitor treatment improves all-cause mortality by 16% in patients with diabetes, including patients with and without hypertension. Patients on ACE inhibitor therapy are at increased risk of cough (SOR: A, meta-analysis of RCTs). ARB therapy doesn't lower the risk of developing kidney disease in normotensive patients with type 2 diabetes (SOR: C, meta-analysis of RCTs, disease-oriented evidence); nor does it reduce all-cause mortality in patients with or without hypertension (SOR: A, meta-analysis of RCTs). ARBs aren't associated with significant adverse events (SOR: A, meta-analysis of RCTs)

Integrating Osteopathic Manipulative Medicine into the Family Medicine Residency: An Introduction

This pre-conference workshop is designed to provide a foundation in osteopathic principles and practice and basic skills in osteopathic diagnosis and manipulative treatment for medical students, residents and family medicine faculty with little to no training in osteopathic medicine. It is also an excellent opportunity for doctors of osteopathic medicine (DOs) to refresh their skills. Upon completion of this session, participants should be able to: Understand the four tenets of osteopathic medicine and their applicability to allopathic as well as osteopathic medicine. Demonstrate the basic osteopathic assessment and treatment of 3–4 common diagnoses that present in outpatient and inpatient family medicine settings. Produce an outline of a training curriculum in osteopathic assessment and treatment for non-DOs within his/her own program using the tools provided by the workshop